Medical/Pharmaceuticals Global News & Press Release Distribution

Medical/Pharmaceuticals

All
APAC

Isotopia Issues a call to action to the radionuclide Therapy industry.

PETAH TIKVA, Israel, Sept. 6, 2023 /PRNewswire/ -- Isotopia Molecular Imaging is a global pharmaceutical company that develops, produces, and distributes therapeutic and diagnostic radioactive isotopes. "If you are in the Lu-177 field, don't miss this information." The Lu-177 radiopharmaceutical...

2023-09-06 20:40 1979

Health In Tech Introduces New Ancillary Products to Expand Healthcare Solutions

Expands Health Care offerings with Critical Illness, Accident, Dental, Vision, Term Life, and Gap coverage options. STUART, Fla., Sept. 6, 2023 /PRNewswire/ -- Health In Tech, an industry-leading insurtech company that delivers disruptive innovation and re-imagines self-funded health plans, is e...

2023-09-06 20:30 2413

Gracell Biotechnologies to Present Updated Clinical Data on BCMA/CD19 Dual-Targeting FasTCAR-T GC012F in Newly Diagnosed Multiple Myeloma at the 2023 International Myeloma Society Annual Meeting

SAN DIEGO, Calif., and SUZHOU and SHANGHAI, China, Sept. 6, 2023 /PRNewswire/ -- Gracell Biotechnologies Inc. ("Gracell" or the "Company", NASDAQ: GRCL), a global clinical-stage biopharmaceutical company dedicated to developing innovative and highly efficacious cell therapies for the treatment o...

2023-09-06 20:00 2517

Gloria Biosciences Announces Zimberelimab Approved in China for the Treatment of Recurrent or Metastatic Cervical Cancer

* The first and only anti-PD-1 antibody approved for treating cervical cancer inChina * ORR of 27.8%, mPFS of 3.7m, and mOS of 16.8m achieved as monotherapy with best-in-class potential * A Phase 3 trial (VICT-004) of zimberelimab in combination with platinum-based chemotherapy +/- bevacizu...

2023-09-06 19:00 2283

CANbridge to Participate in Two Investor Conferences in September

BEIJING and BURLINGTON, Mass., Sept. 6, 2023 /PRNewswire/ -- CANbridge Pharmaceuticals Inc. (HKEX:1228), a global biopharmaceutical company, with a foundation inChina, committed to the research, development and commercialization of transformative rare disease and rare oncology therapies, today a...

2023-09-06 16:06 2404

Exosomes functionally deliver siRNAs in vivo to repress tumor growth

SUZHOU, China, Sept. 5, 2023 /PRNewswire/ -- VesiCURE Therapeutics Co. Ltd., a biotechnology company located in Suzhou,China, recently released a preprint on BioRxiv titled "Harnessing extracellular vesicles for efficient siRNA delivery in vitro and in vivo" (doi:https://doi.org/10.1101/2023.0...

2023-09-05 21:20 2612

Alteogen's Tergase® (Novel Recombinant Human Hyaluronidase Injection) Shows Excellent Immunogenicity Profile

Alteogen expects Tergase® will replace commercially available animal-derived hyaluronidase products and their significant disadvantages. Compared with other commercially available hyaluronidase products, Tergase® showed no incidence of anti-drug antibodies (ADA). The occurrence of ADA is known ...

2023-09-05 20:00 3448

David Topper Joined Inmagene as CFO

SAN DIEGO, Sept. 5, 2023 /PRNewswire/ -- Inmagene Biopharmaceuticals ("Inmagene"), a clinical stage biotechnology company developing innovative and differentiated therapies for immunological and inflammatory diseases, today announced the appointment ofDavid Topper as Chief Financial Officer (C...

2023-09-05 20:00 2607

I-Mab Announces Upcoming Participation at September Conferences

ROCKVILLE, Md. and SHANGHAI, Sept. 5, 2023 /PRNewswire/ -- I-Mab (Nasdaq: IMAB) (the "Company"), is a global biotechnology company focused on bringing highly differentiated medicines to patients around the world through the discovery, development, and commercialization of novel immunotherapies an...

2023-09-05 20:00 2112

Baird Medical's Single-Use Sterile Biopsy Needle Receives Approval from Jiangsu Medical Products Administration in China

GUANGZHOU, China, Sept. 5, 2023 /PRNewswire/ -- Baird Medical Investment Holdings Limited ("Baird Medical" or the "Company"), a leading microwave ablation ("MWA") medical device developer and provider inChina, today announced that its subsidiary, Nanjing Changcheng Medical Equipment Co., Ltd., h...

2023-09-05 17:00 1914

Signia Introduces Hearing Aids That Tackle the Most Difficult Challenge for People With Hearing Loss: Group Conversations in Noise

LYNGE, Denmark, Sept. 5, 2023 /PRNewswire/ -- Hearing aid innovator Signia, part of WS Audiology, today launchesIntegrated Xperience, a breakthrough technology that enables hearing aid wearers to hear all speakers in noisy group conversations clearly. Even when speakers move or the wearer turns t...

2023-09-05 14:00 1916

Signia Introduces Hearing Aids That Tackle the Most Difficult Challenge for People With Hearing Loss: Group Conversations in Noise

GCCL to be the first in the industry sector to adopt Lab Information Management System (LIMS)

* The first clinical trial sample analysis provider to adopt LIMS * To provide enhanced quality of pharmacokinetic, pharmacodynamic, and immunogenicity data from bioanalytic testing YONGIN, South Korea, Sept. 4, 2023 /PRNewswire/ -- GCCL, a Korean clinical trial sample analysis company, annou...

2023-09-05 09:57 1934

Game-changing Virtuoso Digital Front Door technology radically rewires healthcare

World-first technology launches to unlock preventative, proactive and predictive healthcare BOSTON, Sept. 4, 2023 /PRNewswire/ -- Global leader in population health, Orion Health, is ushering in the next era of health – moving from institution-centric reactive sick care to people-centered preven...

2023-09-04 21:00 2625

ABM Therapeutics Announces First Patient Dosed in Phase I Study of ABM-1310 in patients with BRAF V600 in Relapsed and Drug Resistant Primary Malignant Brain Tumors

SAN DIEGO, Calif. and SHANGHAI, Sept. 1, 2023 /PRNewswire/ -- ABM Therapeutics, a clinical-stage biopharmaceutical company, today announced that the first patient has been successfully dosed in its multicenter Phase I study of ABM-1310 in patients with relapsed and drug resistant primary malignan...

2023-09-02 00:00 4182

Adicon Holdings Limited (9860.HK): Continuous growth in Core Operations, Consistent Profitability Enhancement

HANGZHOU, China, Sept. 1, 2023 /PRNewswire/ -- Adicon Holdings Limited (the "Company" or "Adicon"), one of the largest independent clinical laboratory (ICL) service providers listed on the Stock Exchange ofHong Kong (SEHK), has released its interim results for the first half of 2023. As a leading...

2023-09-01 21:30 6989

Innovac Therapeutics Completes $18 million Series Pre-A Financing To Fund the Development of Its lead Programs and Manufacturing Capabilities

The funding represents a strong endorsement of Innovac's technology, mission and vision from a range of industry Investors BOSTON, SHANGHAI and HANGZHOU, China, Sept. 1, 2023 /PRNewswire/ -- Innovac Therapeutics, an mRNA therapeutics company, today announced the completion of an $18 million Seri...

2023-09-01 20:08 2609

Peijia Medical Announces 2023 Interim Results

HONG KONG , Sept. 1, 2023 /PRNewswire/ -- Peijia Medical (HKG:9996), a leading Chinese domestic player in the high-growth transcatheter valve therapeutic and neurointerventional procedural medical device markets, today announced financial results for the six months endedJune 30, 2023 ("the period...

2023-09-01 19:00 5602

CANbridge Announces Interim Financial Results and Corporate Updates for the Six Months Ended June 30, 2023

BEIJING and CAMBRIDGE, Mass., Aug. 31, 2023 /PRNewswire/ -- CANbridge Pharmaceuticals, Inc. ("CANbridge," stock code 1228.HK), a global biopharmaceutical company, with a foundation inChina, committed to the research, development and commercialization of transformative therapies for rare diseases...

2023-08-31 15:15 4883

Tycoon Group Announces 2023 Interim Results

The Group's Revenue Hits New Heights Net profit for 1H2023 increased more than 2.8 times YoY Benefited from the Full Resumption of Normal Travel Revenue Continues to Generate Profit in Future Results Highlights * Since the full resumption of normal travel between Hong Kong, Macau and Mainland C...

2023-08-31 13:28 5274

Zylox-Tonbridge's ZENFlow Tiger™ LD PTA Dilatation Catheter Receives ANVISA Marketing Approval

HANGZHOU, China, Aug. 30, 2023 /PRNewswire/ -- Zylox-Tonbridge Medical Technology Co., Ltd. (2190.HK, hereinafter referred to as "Zylox-Tonbridge" or the "Company") announced that its ZENFlow Tiger™ LD PTA Dilatation Catheter (hereinafter referred to as "ZENFlow Tiger™"), a product independently ...

2023-08-31 11:31 2531

1 ... 171 172 173174175 176 177 ... 263